SCHEMBL25690322

SCHEMBL25690322

CNC(=O)c1ccc(C)c(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.44
▸ RAB9A P51151 2/20 0.42
▸ CNR1 P21554 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ P2RX7 Q99572 1/20 0.42
▸ BAZ2B Q9UIF8 1/20 0.42
▸ SCN10A Q9Y5Y9 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ SCN1A P35498 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SCN5A Q14524 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ SCN2A Q99250 1/20 0.40
▸ SCN3A Q9NY46 1/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ DPP8 Q6V1X1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27203114 0.82 BRD4 (0.42) BRD4RAB9ACNR1NPC1POLB
SCHEMBL25690235 0.81 BRD4 (0.41) BRD4RAB9ACNR1NPC1POLB
SCHEMBL22912737 0.81 RAB9A (0.46) BRD4RAB9ACNR1NPC1POLB
SCHEMBL25690329 0.81 BRD4 (0.41) BRD4RAB9ACNR1NPC1POLB
SCHEMBL27398469 0.81 SCN10A (0.46) BRD4RAB9ACNR1NPC1POLB
SCHEMBL14525219 0.81 BRD4 (0.41) BRD4RAB9ACNR1NPC1POLB
SCHEMBL31224086 0.81 GAA (0.43) BRD4RAB9ACNR1NPC1POLB
SCHEMBL25918942 0.79 BRD4 (0.44) BRD4RAB9ACNR1NPC1POLB
SCHEMBL25690604 0.79 KDM4E (0.42) RAB9ANPC1P2RX7ALDH1A1KDM4E
SCHEMBL25698386 0.79 CNR1 (0.47) BRD4RAB9ACNR1NPC1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050370-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF 1CBIO, INC. (US) 2024-03-07 — — WO disclosed
WO-2023134647-A1 PIPERAZINO RING-CONTAINING DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 优领医药科技(香港)有限公司 2023-07-20 — — WO disclosed
WO-2023122140-A1 PARP1 INHIBITORS SYNNOVATION THERAPEUTICS, INC. (US) 2023-06-29 — — WO disclosed
Send feedback